Axin PPI Networks: New Interacting Proteins and New Targets?

Area of Science:

• Molecular Biology
• Cell Signaling
• Oncology

Background:

• Axin is a scaffold protein regulating multiple signaling pathways, notably as a negative regulator of the Wnt/β-catenin pathway.
• Dysregulation of Axin and the Wnt/β-catenin pathway is implicated in various human cancers.
• Current therapeutic targets in this pathway are limited, particularly enzymes, highlighting a need for novel strategies.

Purpose of the Study:

• To review the Axin protein-protein interaction (PPI) networks across different signaling pathways, with a focus on Wnt signaling.
• To discuss the role of Axin-interacting proteins in modulating signaling pathways relevant to human diseases.
• To explore Axin PPI networks as a source for novel drug targets and therapeutic strategies.

Main Methods:

• Literature review of studies identifying Axin interacting partners.
• Analysis of the functional roles of Axin-mediated protein-protein interactions (PPIs).
• Examination of Axin's involvement in Wnt signaling and other disease-relevant pathways.

Main Results:

• Axin mediates numerous protein-protein interactions (PPIs) that are central to signal transduction.
• These Axin-mediated PPIs play critical roles in regulating pathways involved in human disease pathogenesis.
• Axin itself is a promising target for Wnt-driven diseases, with its PPI network offering further avenues.

Conclusions:

• Axin's extensive PPI network is fundamental to its function in various signaling pathways, especially Wnt signaling.
• Understanding these Axin-mediated PPIs is key to uncovering new therapeutic targets for Wnt-driven diseases.
• Targeting Axin-associated PPIs represents a promising future direction for drug discovery and treatment strategies.